We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Teleflex Inc (TFX) Com Stk USD1

Sell:$256.67 Buy:$256.82 Change: $3.57 (1.41%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
Change: $3.57 (1.41%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
Change: $3.57 (1.41%)
Market closed |  Prices as at close on 29 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas, Europe, the Middle East and Africa (EMEA), Asia Pacific (Asia) and Original Equipment Manufacturer and Development Services (OEM). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. It includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, specialized sutures and performance fibers, bioabsorbable sutures, yarns and resins.

Contact details

United States
+1 (610) 9485100

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$11.88 billion
Shares in issue:
46.90 million
Health Care Equipment
New York Stock Exchange
United States
US dollar

Key personnel

  • Liam Kelly
    Chairman of the Board, President, Chief Executive Officer
  • Thomas Powell
    Chief Financial Officer, Executive Vice President
  • Daniel Logue
    Corporate Vice President, General Counsel and Secretary
  • Cameron Hicks
    Corporate Vice President - Human Resources and Communications
  • Jay White
    Corporate Vice President and President, Global Commercial
  • James Winters
    Corporate Vice President - Manufacturing and Supply Chain

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.